2008•Unpublished venueRequires access

Bioequivalence of omeprazole enteric capsule

Zhuang Ren

Open publisher page 0 citations

Abstract

Objective: To evaluate the pharmacokinetics and bioequivalence of omeprazole enteric capsule in heslthy Chinese.Methods: Randomized cross-over design was adopted,18 healthy subjects took omeprazole enteric capsule and reference preparation 40 mg orally in one time.Serial blood samples were collected at scheduled intervals during 12 h.The samples were analyzed for omeprazole and reference preparation concentration in plasma by HPLC.The main pharmacokinetics parameters of the omeprazole and reference preparation were Calculated and analyzed.Results: The main pharmacokinetic parameters in test and reference preparation were following accordingly: Tmax were 2.39±0.40 and 2.33±0.42 h;Cmax were 0.632±0.383 and 0.626±0.415 mg/L;T1/2 were 1.92±0.64 and 2.01±0.73 h;Vd/F were 81.21±46.68 and 94.07±89.46 L;CL/F were 32.99±20.92 and 31.68±20.41 L/h;AUC0→12 were 2.03±1.99 and 1.89±1.62 mg/(h·L)-1.The relative bioavailability of omeprazole was 104.7±17.7%.Conclusion: The two omeprazole preparations are bioequivalent.

About this research paper

What this paper is about

Objective: To evaluate the pharmacokinetics and bioequivalence of omeprazole enteric capsule in heslthy Chinese.Methods: Randomized cross-over design was adopted,18 healthy subjects took omeprazole enteric capsule and reference preparation 40 mg orally in one time.Serial blood samples were collected at scheduled intervals during 12 h.The samples were analyzed for omeprazole and reference preparation concentration in plasma by HPLC.The main pharmacokinetics parameters of the omeprazole and reference preparation were Calculated and analyzed.Results: The main pharmacokinetic parameters in test and reference preparation were following accordingly: Tmax were 2.39±0.40 and 2.33±0.42 h;Cmax were 0.632±0.383 and 0.626±0.415 mg/L;T1/2 were 1.92±0.64 and 2.01±0.73 h;Vd/F were 81.21±46.68 and 94.07±89.46 L;CL/F were 32.99±20.92 and 31.68±20.41 L/h;AUC0→12 were 2.03±1.99 and 1.89±1.62 mg/(h·L)-1.The relative bioavailability of omeprazole was 104.7±17.7%.Conclusion: The two omeprazole preparations are bioequivalent.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To evaluate the pharmacokinetics and bioequivalence of omeprazole enteric capsule in heslthy Chinese.Methods: Randomized cross-over design was adopted,18 healthy subjects took omeprazole enteric capsule and reference preparation 40 mg orally in one time.Serial blood samples were collected at scheduled intervals during 12 h.The samples were analyzed for omeprazole and reference preparation concentration in plasma by HPLC.The main pharmacokinetics parameters of the omeprazole and reference preparation were Calculated and analyzed.Results: The main pharmacokinetic parameters in test and reference preparation were following accordingly: Tmax were 2.39±0.40 and 2.33±0.42 h;Cmax were 0.632±0.383 and 0.626±0.415 mg/L;T1/2 were 1.92±0.64 and 2.01±0.73 h;Vd/F were 81.21±46.68 and 94.07±89.46 L;CL/F were 32.99±20.92 and 31.68±20.41 L/h;AUC0→12 were 2.03±1.99 and 1.89±1.62 mg/(h·L)-1.The relative bioavailability of omeprazole was 104.7±17.7%.Conclusion: The two omeprazole preparations are bioequivalent.

Key concepts: Omeprazole, Bioequivalence, Cmax, Pharmacokinetics, Capsule, Medicine, Bioavailability, Pharmacology

Related papers

Back to paper searchBrowse research topicsOriginal source
Bioequivalence of omeprazole enteric capsule — Research Paper | ScholarLens